Exelixis Inc (EXEL)
23.70
+0.16
(+0.70%)
USD |
NASDAQ |
Apr 26, 16:00
23.70
0.00 (0.00%)
After-Hours: 19:48
Exelixis Market Cap: 7.184B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 7.134B |
| April 24, 2024 | 7.189B |
| April 23, 2024 | 7.061B |
| April 22, 2024 | 6.934B |
| April 19, 2024 | 6.828B |
| April 18, 2024 | 6.819B |
| April 17, 2024 | 6.934B |
| April 16, 2024 | 6.919B |
| April 15, 2024 | 6.883B |
| April 12, 2024 | 6.916B |
| April 11, 2024 | 6.867B |
| April 10, 2024 | 7.180B |
| April 09, 2024 | 7.192B |
| April 08, 2024 | 7.080B |
| April 05, 2024 | 7.016B |
| April 04, 2024 | 7.122B |
| April 03, 2024 | 7.183B |
| April 02, 2024 | 7.077B |
| April 01, 2024 | 7.180B |
| March 28, 2024 | 7.195B |
| March 27, 2024 | 7.234B |
| March 26, 2024 | 7.158B |
| March 25, 2024 | 7.186B |
| March 22, 2024 | 7.210B |
| March 21, 2024 | 7.252B |
| Date | Value |
|---|---|
| March 20, 2024 | 7.189B |
| March 19, 2024 | 7.116B |
| March 18, 2024 | 7.025B |
| March 15, 2024 | 6.967B |
| March 14, 2024 | 6.855B |
| March 13, 2024 | 6.995B |
| March 12, 2024 | 6.879B |
| March 11, 2024 | 6.810B |
| March 08, 2024 | 6.734B |
| March 07, 2024 | 6.698B |
| March 06, 2024 | 6.785B |
| March 05, 2024 | 6.749B |
| March 04, 2024 | 6.837B |
| March 01, 2024 | 6.743B |
| February 29, 2024 | 6.640B |
| February 28, 2024 | 6.643B |
| February 27, 2024 | 6.582B |
| February 26, 2024 | 6.658B |
| February 23, 2024 | 6.528B |
| February 22, 2024 | 6.279B |
| February 21, 2024 | 6.282B |
| February 20, 2024 | 6.255B |
| February 16, 2024 | 6.209B |
| February 15, 2024 | 6.243B |
| February 14, 2024 | 6.182B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.417B
Minimum
Mar 16 2020
8.409B
Maximum
May 11 2020
6.334B
Average
6.307B
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 96.91B |
| Bristol-Myers Squibb Co | 90.72B |
| Johnson & Johnson | 351.13B |
| Bio-Techne Corp | 10.08B |
| Legend Biotech Corp | 8.241B |
Market Cap Related Metrics
| PE Ratio | 36.84 |
| PS Ratio | 4.162 |
| PEG Ratio | 2.866 |
| Price to Book Value | 3.173 |
| Price to Free Cash Flow | 44.71 |
| Price | 23.70 |
| Earnings Yield | 2.71% |
| PEGY Ratio | 2.866 |
| Operating PE Ratio | 44.57 |
| Normalized PE Ratio | 36.84 |